Descrizione

Clinical response rates for curcumin-supplemented ulcerative colitis patients are analyzed in a meta-analytic framework. Effect sizes across individual trials and the pooled estimate indicate a positive treatment effect.

Figure 4

Forest Plot

Source Paper

Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nutrients (2018)

PMID: 30424514

DOI: 10.3390/nu10111737

Cite This Figure

![Figure 4: Clinical response rates for curcumin-supplemented ulcerative colitis patients are analyzed in a meta-analytic framework. Effect sizes across individual trials and the pooled estimate indicate a positive treatment effect.]()

> Source: Maria G Grammatikopoulou et al. "Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Co." *Nutrients*, 2018. PMID: [30424514](https://pubmed.ncbi.nlm.nih.gov/30424514/)

<figure>
  <img src="" alt="Clinical response rates for curcumin-supplemented ulcerative colitis patients are analyzed in a meta-analytic framework. Effect sizes across individual trials and the pooled estimate indicate a positive treatment effect." />
  <figcaption>Figure 4. Clinical response rates for curcumin-supplemented ulcerative colitis patients are analyzed in a meta-analytic framework. Effect sizes across individual trials and the pooled estimate indicate a positive treatment effect.<br>  Source: Maria G Grammatikopoulou et al. "Oral Adjuvant Curcumin Therapy for Attaining Clinical Remission in Ulcerative Co." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30424514/">30424514</a></figcaption>
</figure>

Evidenze correlate

Curcumin per Ulcerative Colitis (UC)

Grado B · 5 studi